Eric Merle

Eric leads their business innovation efforts and strategic development. He joined Genoskin in 2018. Eric has spent his career developing commercial and corporate strategies globally for some of the life science industry’s most recognizable companies. Previously at Intrexon (XON), he led the development of the consumer sector portfolio and business strategy as the Senior Director of Strategic Alliances and Innovation. Prior to Intrexon, Eric developed growth strategies for the Life Sciences division of SGS (SGSN), the world’s leading inspection, verification, testing, and certification company. He has also held commercial roles at Cellectis (CLLS), Sigma Aldrich (SIAL), Becton Dickinson (BDX), and Fisher Scientific (TMO).